Log in

Relevant bibliographies by topics / Proliferative vitreoretinopath / Journal articles

To see the other types of publications on this topic, follow the link: Proliferative vitreoretinopath.

Journal articles on the topic 'Proliferative vitreoretinopath'

Author: Grafiati

Published: 4 June 2021

Last updated: 28 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Proliferative vitreoretinopath.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lewis, Hilel, Janice M. Burke, Gary W. Abrams, and Thomas M. Aaberg. "Perisilicone Proliferation after Vitrectomy for Proliferative Vitreoretinopathy." Ophthalmology 95, no. 5 (1988): 583–91. http://dx.doi.org/10.1016/s0161-6420(88)33136-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hatchell, D. L., T. McAdoo, S. Sheta, R. T. King, and J. V. Bartolome. "Quantification of Cellular Proliferation in Experimental Proliferative Vitreoretinopathy." Archives of Ophthalmology 106, no. 5 (1988): 669–72. http://dx.doi.org/10.1001/archopht.1988.01060130731033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

NAQVI, SYED ABID HASSAN, SOHAIL SHEHZAD, and OMAR ZAFAR. "PROLIFERATIVE VITREORETINOPATHY." Professional Medical Journal 13, no. 01 (2006): 42–46. http://dx.doi.org/10.29309/tpmj/2006.13.01.5055.

Full text

Abstract:

Objective: The objective of study to assess the success of pars planavitrectomy with use of silicone Oil for internal tamponade in traumatic rhegmatogenous R D with severe PVR. Setting& Period: This study was carried out in department of Ophthalmology Military Hospital Rawalpindi. Material &Methods: Fifteen cases with severe proliferative vitreoretinopathy (PVR Grade C, according to up dated retina SocietyClassification of 1991) was included in study. All the patients had traumatic rhegmatogenous retinal detachment withhistory of blunt ocular trauma, without globe rupture, outcome of t

APA, Harvard, Vancouver, ISO, and other styles

4

Chaum, Edward. "Proliferative Vitreoretinopathy." International Ophthalmology Clinics 35, no. 1 (1995): 163–73. http://dx.doi.org/10.1097/00004397-199503510-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

WILKES, SHELBY R., AHMAD M. MANSOUR, and W. RICHARD GREEN. "PROLIFERATIVE VITREORETINOPATHY." Retina 7, no. 2 (1987): 94–101. http://dx.doi.org/10.1097/00006982-198700720-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

SCHWARTZ, DANIEL, ZENAIDA C. DE LA CRUZ, RICHARD W. GREEN, and RONALD G. MICHELS. "PROLIFERATIVE VITREORETINOPATHY." Retina 8, no. 4 (1988): 275–81. http://dx.doi.org/10.1097/00006982-198808040-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Blumenkranz, Mark S. "Proliferative Vitreoretinopathy." Retina 12, no. 1 (1992): 70. http://dx.doi.org/10.1097/00006982-199212010-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Wiedemann, Peter, and Klaus Heimann. "Proliferative vitreoretinopathy." Current Opinion in Ophthalmology 3, no. 3 (1992): 357–65. http://dx.doi.org/10.1097/00055735-199206000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Coffee, Robert E., Lai Jiang, and Salman A. Rahman. "Proliferative Vitreoretinopathy." International Ophthalmology Clinics 54, no. 2 (2014): 91–109. http://dx.doi.org/10.1097/iio.0000000000000023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Idrees, Sana, Jayanth Sridhar, and Ajay E. Kuriyan. "Proliferative Vitreoretinopathy." International Ophthalmology Clinics 59, no. 1 (2019): 221–40. http://dx.doi.org/10.1097/iio.0000000000000258.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Charteris, David G., Paul Hiscott, Ian Grierson, and Susan L. Lightman. "Proliferative Vitreoretinopathy." Ophthalmology 99, no. 9 (1992): 1364–67. http://dx.doi.org/10.1016/s0161-6420(92)31793-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Schwartz, Steven D., and Allan E. Kreiger. "Proliferative vitreoretinopathy." Ophthalmology 105, no. 5 (1998): 785–88. http://dx.doi.org/10.1016/s0161-6420(98)95015-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Leaver, P. K. "Proliferative vitreoretinopathy." British Journal of Ophthalmology 79, no. 10 (1995): 871–72. http://dx.doi.org/10.1136/bjo.79.10.871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Tennant, Matthew T. S., Mark L. Nelson, Kent A. Blade, Sunir J. Garg, and Richard G. Lane. "Proliferative Vitreoretinopathy." Ophthalmology 114, no. 9 (2007): 1793–94. http://dx.doi.org/10.1016/j.ophtha.2007.03.044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Barile, Gaetano, Stanley Chang, and William Schiff. "Proliferative Vitreoretinopathy." Ophthalmology 114, no. 9 (2007): 1794. http://dx.doi.org/10.1016/j.ophtha.2007.04.028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Pastor, J. Carlos. "Proliferative Vitreoretinopathy." Survey of Ophthalmology 43, no. 1 (1998): 3–18. http://dx.doi.org/10.1016/s0039-6257(98)00023-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Shamkin, S. S., S. N. Subbotina, and A. B. Stepanyants. "Proliferative vitreoretinopathy and it's prevention in cases of extensive penetrating wounds of the sclera." Fyodorov journal of ophthalmic surgery, no. 3S (December 7, 2023): 116–20. http://dx.doi.org/10.25276/0235-4160-2023-3s-116-120.

Full text

Abstract:

Relevance. Currently, there is no single algorithm for the management of patients with extensive penetrating wounds of the sclera, and the frequency of proliferative vitreoretinopathy, leading to adverse outcomes, is very high. Purpose. To present relevant data about prevention of proliferative vitreoretinopathy with extensive penetrating wounds of the sclera, as well as to identify the most effective methods. Material and methods. To complete this review, a literature search was carried out on the databases CyberLeninka, eLIBRARY, PubMed, using the keywords «proliferative vitreoretinopathy»,

APA, Harvard, Vancouver, ISO, and other styles

18

Park, Young Hoon, Bong Hwan Lee, and Duk Kee Hahn. "Experimental proliferative vitreoretinopathy." Yeungnam University Journal of Medicine 8, no. 1 (1991): 178. http://dx.doi.org/10.12701/yujm.1991.8.1.178.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Jerdan, Janice A., Jay S. Pepose, Ronald G. Michels, et al. "Proliferative Vitreoretinopathy Membranes." Ophthalmology 96, no. 6 (1989): 801–10. http://dx.doi.org/10.1016/s0161-6420(89)32818-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Lewis, Hilel, and Thomas M. Aaberg. "Anterior Proliferative Vitreoretinopathy." American Journal of Ophthalmology 105, no. 3 (1988): 277–84. http://dx.doi.org/10.1016/0002-9394(88)90010-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Gregor, Z. J. "Proliferative Vitreoretinopathy (PVR)." British Journal of Ophthalmology 74, no. 4 (1990): 255. http://dx.doi.org/10.1136/bjo.74.4.255.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Jin, Ying, Huijin Chen, Xiaojian Xu, Yuntao Hu, Changguan Wang, and Zhizhong Ma. "TRAUMATIC PROLIFERATIVE VITREORETINOPATHY." Retina 37, no. 7 (2017): 1236–45. http://dx.doi.org/10.1097/iae.0000000000001350.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Wiedemann, P., and A. Bringmann. "Die proliferative Vitreoretinopathie." Klinische Monatsblätter für Augenheilkunde 233, no. 09 (2016): 1012–15. http://dx.doi.org/10.1055/s-0042-109704.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Baudouin, Ch, Fr Brignole, D. Fredj-Reygrobellet, Ph Lapalus, and P. Gastaud. "Class II antigen expression by proliferating RPE cells in proliferative vitreoretinopathy." Experimental Eye Research 55 (September 1992): 139. http://dx.doi.org/10.1016/0014-4835(92)90696-p.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Yang, Chung-May, Karl R. Olsen, Eleut Hernandez, and Scott W. Cousins. "Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy." Graefe's Archive for Clinical and Experimental Ophthalmology 230, no. 1 (1992): 66–71. http://dx.doi.org/10.1007/bf00166765.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Kruger, Erik F., Quan Dong Nguyen, Meisy Ramos-Lopez, and Kameran Lashkari. "Proliferative Vitreoretinopathy After Trauma." International Ophthalmology Clinics 42, no. 3 (2002): 129–43. http://dx.doi.org/10.1097/00004397-200207000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Cardillo, Jose A., J. Timothy Stout, Laurie LaBree, et al. "Post-traumatic Proliferative Vitreoretinopathy." Ophthalmology 104, no. 7 (1997): 1166–73. http://dx.doi.org/10.1016/s0161-6420(97)30167-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

El Ghrably, I. "Apoptosis in Proliferative Vitreoretinopathy." Investigative Ophthalmology & Visual Science 45, no. 5 (2004): 1473–79. http://dx.doi.org/10.1167/iovs.03-0060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

KIM, I., and J. ARROYO. "Mechanisms in proliferative vitreoretinopathy." Ophthalmology Clinics of North America 15, no. 1 (2002): 81–86. http://dx.doi.org/10.1016/s0896-1549(01)00008-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Limb, G. A., B. C. Little, A. Meager, et al. "Cytokines in proliferative vitreoretinopathy." Eye 5, no. 6 (1991): 686–93. http://dx.doi.org/10.1038/eye.1991.126.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Carpineto, Paolo, Arturo Maria Licata, and Marco Ciancaglini. "Proliferative Vitreoretinopathy: A Reappraisal." Journal of Clinical Medicine 12, no. 16 (2023): 5287. http://dx.doi.org/10.3390/jcm12165287.

Full text

Abstract:

Proliferative vitreoretinopathy (PVR) remains the main cause of failure after retinal detachment (RD) surgery. Despite the development of modern technologies and sophisticated techniques for the management of RD, the growth of fibrocellular membranes within the vitreous cavity and on both sides of the retinal surface, as well as intraretinal fibrosis, can compromise surgical outcomes. Since 1983, when the term PVR was coined by the Retina Society, a lot of knowledge has been obtained about the physiopathology and risk factors of PVR, but, despite the proposal of a lot of therapeutic challenges

APA, Harvard, Vancouver, ISO, and other styles

32

Resch, Miklós, and Anikó Balogh. "Proliferatív vitreoretinopathia." Szemészet 159, no. 2 (2022): 51–61. http://dx.doi.org/10.55342/szemhungarica.2022.159.2.51.

Full text

Abstract:

A proliferatív vitreoretinopathia (PVR) egy kóros állapot, amelyhez számos vitreoretinális kórkép, elsődlegesen a retinaleválás vezet. Az egyre bővülő molekuláris biológiai tudás, az arra épített farmakológiai fejlesztések ellenére jelenleg is elsődlegesen sebészi úton ellátandó betegség, amelynek számos kockázati tényezője van. Komplexitásában nézve a műtéti technika és vizualizáció nagyléptékű fejlődése mellett sem sikerült megszüntetni ezt a látást veszélyeztető kórképet és továbbra is jelentős kihívást jelent a jelenlegi és jövőbeli vitreoretinális sebészek és általános szemészek számára e

APA, Harvard, Vancouver, ISO, and other styles

33

Krupina, E. A., O. A. Pavlovsky, and E. A. Larina. "Subretinal proliferation. What to do?" Modern technologies in ophtalmology, no. 3 (July 15, 2021): 90–93. http://dx.doi.org/10.25276/2312-4911-2021-3-90-93.

Full text

Abstract:

Purpose. Evaluation of treatment results retinal detachment complicated by subretinal PVR. Materials and methods. We examined 13 patients (13 eyes) with operated retinal detachment (RD), subretinal proliferative vitreoretinopathy (PVR). In the main group (7 eyes) with recurrence of retinal detachment RD was complicated by severe subretinal proliferation. Аll the patients underwent surgical treatment of retinal detachment with removal of the subretinal PVR; in the control group (6 eyes) subretinal proliferation was localized in the zone of the adjacent retina and its removal was not performed.

APA, Harvard, Vancouver, ISO, and other styles

34

Schaub, F., P. Enders, and S. Fauser. "Proliferative Vitreoretinopathie: therapeutische Strategien." Klinische Monatsblätter für Augenheilkunde 233, no. 09 (2016): 1016–23. http://dx.doi.org/10.1055/s-0042-107947.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Wu, Frances, and Dean Eliott. "Molecular Targets for Proliferative Vitreoretinopathy." Seminars in Ophthalmology 36, no. 4 (2021): 218–23. http://dx.doi.org/10.1080/08820538.2021.1890791.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Sun, Jennifer K., and Jorge G. Arroyo. "Adjunctive Therapies for Proliferative Vitreoretinopathy." International Ophthalmology Clinics 44, no. 3 (2004): 1–10. http://dx.doi.org/10.1097/00004397-200404430-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Khan, Mohammed A., Christopher J. Brady, and Richard S. Kaiser. "CLINICAL MANAGEMENT OF PROLIFERATIVE VITREORETINOPATHY." Retina 35, no. 2 (2015): 165–75. http://dx.doi.org/10.1097/iae.0000000000000447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Nagasaki, Hiroshi, and Kouichi Shinagawa. "Risk factors for proliferative vitreoretinopathy." Current Opinion in Ophthalmology 6, no. 3 (1995): 70–75. http://dx.doi.org/10.1097/00055735-199506000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

JONAS, JB. "How to prevent proliferative vitreoretinopathy ?" Acta Ophthalmologica 90 (August 6, 2012): 0. http://dx.doi.org/10.1111/j.1755-3768.2012.1554.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Kubota, Toshiaki, Kasumi Kurihara, Tatsuro Ishibashi, and Hajime Inomata. "Proliferative Vitreoretinopathy in Coats’ Disease." Ophthalmologica 209, no. 1 (1995): 44–46. http://dx.doi.org/10.1159/000310576.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Baudouin, Christophe, Danielle Fredj-Reygrobellet, Françoise Baudouin, Philippe Lapalus, and Pierre Gastaud. "Immunohistologic Study of Proliferative Vitreoretinopathy." American Journal of Ophthalmology 108, no. 4 (1989): 387–94. http://dx.doi.org/10.1016/s0002-9394(14)73306-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Comaratta, Mark R., Stanley Chang, and Janet Sparrow. "Iris Neovascularizadon in Proliferative Vitreoretinopathy." Ophthalmology 99, no. 6 (1992): 898–905. http://dx.doi.org/10.1016/s0161-6420(92)31889-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Nagasaki, Hiroshi, Kouichi Shinagawa, and Manabu Mochizuki. "Risk factors for proliferative vitreoretinopathy." Progress in Retinal and Eye Research 17, no. 1 (1998): 77–98. http://dx.doi.org/10.1016/s1350-9462(97)00007-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Hwang, Cindy S., Pia R. Mendoza, Jill R. Wells, Hans E. Grossniklaus, and G. Baker Hubbard. "Proliferative Vitreoretinopathy in Treated Retinoblastoma." Ophthalmology Retina 1, no. 2 (2017): 165–72. http://dx.doi.org/10.1016/j.oret.2016.09.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

CHARTERIS, D. G. "Growth factors in proliferative vitreoretinopathy." British Journal of Ophthalmology 82, no. 2 (1998): 106. http://dx.doi.org/10.1136/bjo.82.2.106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Sakamoto, Taiji. "Animal Model of Proliferative Vitreoretinopathy." Japanese Journal of Pharmacology 82 (2000): 19. http://dx.doi.org/10.1016/s0021-5198(19)47554-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Danis, Ronald P., and Toichiro Kuwabara. "Proliferative Vitreoretinopathy in Fundus Flavimaculatus." American Journal of Ophthalmology 113, no. 6 (1992): 713–14. http://dx.doi.org/10.1016/s0002-9394(14)74801-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Asaria, Riaz Hassan Yusuf, Chee Hing Kon, Catey Bunce, et al. "How to predict proliferative vitreoretinopathy." Ophthalmology 108, no. 7 (2001): 1184–86. http://dx.doi.org/10.1016/s0161-6420(01)00553-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Yoon, Young Doo, Thomas M. Aaberg, Ted H. Wojno, and Hans E. Grossniklaus. "Osseous metaplasia in proliferative vitreoretinopathy." American Journal of Ophthalmology 125, no. 4 (1998): 558–59. http://dx.doi.org/10.1016/s0002-9394(99)80201-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Radtke, N. D., A. D. Weinsieder, and R. J. Ballou. "Pharmacological therapy for proliferative vitreoretinopathy." Graefe's Archive for Clinical and Experimental Ophthalmology 224, no. 3 (1986): 230–33. http://dx.doi.org/10.1007/bf02143060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!